Form D · Biotechnology

OverT Bio, Inc.

New York, NY · CIK 0001973901

Offering snapshot reported May 9, 2024 · SEC filing

Reported sold
$16M
Offering amount: $17M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 4, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.99M$16MMay 3, 2023: $4,487,481.00May 3, 2023May 9, 2024: $15,989,924.00May 9, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,487,481 → $15,989,924
  • Reported investors11 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 9, 2024Amendment$15,989,924$11,502,443vs May 3, 202315SEC filing
May 3, 2023Initial$4,487,481No comparison11SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-480712

Source: Form D, filed May 9, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Vasudev Bailey Director
Sara Choi Director
Mateusz Legut Director, Executive
Neville Sanjana Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
430 E 29 Th St 14 Fl
New York, NY, 10016